TickerFacts.

Compugen Ltd (CGEN): Cost of Revenue

Annual figures by period end, from SEC filings.

$9.25M
Year ended 2025-12-31
+111.7%
3-year compound annual growth
n/m
5-year compound annual growth
+18.9%
10-year compound annual growth
2010-12-31: $224.0K2012-12-31: $201.0K2013-12-31: $2.51M2014-12-31: $3.34M2015-12-31: $1.63M2016-12-31: $223.0K2018-12-31: $1.03M2020-12-31: $60.0K2021-12-31: $680.0K2022-12-31: $975.0K2023-12-31: $2.00M2024-12-31: $7.93M2025-12-31: $9.25M$9.25M
2010-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$9.25M+16.7%2026-03-02, From 2025-01-01
2024-12-31$7.93M+295.7%2026-03-02, From 2024-01-01
2023-12-31$2.00M+105.5%2026-03-02, From 2023-01-01
2022-12-31$975.0K+43.4%2025-03-04, From 2022-01-01
2021-12-31$680.0Kn/m2024-03-05, From 2021-01-01
2020-12-31$60.0Kn/a2023-08-23, From 2020-01-01
No annual figure between 2018-12-31 and 2020-12-31.
2018-12-31$1.03Mn/a2021-02-25, From 2018-01-01
No annual figure between 2016-12-31 and 2018-12-31.
2016-12-31$223.0K-86.3%2019-03-21, From 2016-01-01
2015-12-31$1.63M-51.2%2018-03-27, From 2015-01-01
2014-12-31$3.34M+33.3%2017-02-16, From 2014-01-01
2013-12-31$2.51Mn/m2016-03-07, From 2013-01-01
2012-12-31$201.0Kn/a2015-03-12, From 2012-01-01
No annual figure between 2010-12-31 and 2012-12-31.
2010-12-31$224.0Kn/a2013-03-21, From 2010-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Compugen Ltd (CGEN)2025-12-31$9.25M+16.7%
Recursion Pharmaceuticals, Inc. (RXRX)2025-12-31$70.95M+56.8%
Autolus Therapeutics plc (AUTL)2025-12-31$96.37M+746.3%
Vir Biotechnology, Inc. (VIR)2025-12-31$26.0K-96.9%
Champions Oncology, Inc. (CSBR)2026-04-30$30.90M+8.8%
Protalix BioTherapeutics, Inc. (PLX)2025-12-31$26.99M+11.0%
ImmunityBio, Inc. (IBRX)2025-12-31$753.0Kn/a
Agenus Inc (AGEN)2025-12-31$1.02M+110.3%
Kymera Therapeutics, Inc. (KYMR)2025-12-31$39.21M-16.7%

Compare CGEN, RXRX, AUTL, VIR side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗